about
Sources of variability of resting cerebral blood flow in healthy subjects: a study using ¹³³Xe SPECT measurementsPearls and pitfalls in human pharmacological models of migraine: 30 years' experience.Migraine aura: new ideas about cause, classification, and clinical significance.Cerebral hemodynamics in the different phases of migraine and cluster headache.The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine.Coexisting typical migraine in familial hemiplegic migraine.Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features.Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording.EHMTI-0044. Variability of clinical features in attacks of migraine with aura.EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura.Trigger factors for familial hemiplegic migraine.Habituation of evoked responses is greater in patients with familial hemiplegic migraine than in controls: a contrast with the common forms of migraine.Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic MigraineCalcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with auraCalcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotypeFamilial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric OxideFamilial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of MigraineVasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce MigraineHemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phasePharmacological migraine provocation: a human model of migraineVasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptanRed and orange flags for secondary headaches in clinical practice: SNNOOP10 listOpening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraineMore precise phenotyping of cluster headache using prospective attack reportsMigraine and the trigeminovascular system-40 years and countingDifferences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTsGuidelines for controlled trials of drugs in migraine: third edition. A guide for investigators
P50
Q36839954-EF66C402-C93C-45BA-83B1-4CAE67D2CAA6Q38106681-622C7B5E-AE7B-4E8E-8D04-038CBA4A79FCQ38448754-AEAA470F-269E-4822-891C-5D319E2D6996Q38635129-4B0C3A64-2BA4-4562-A1CF-264E1DA3F8E9Q41492299-7D6ED987-E2BF-4B90-9981-24A032F9AAF5Q43161371-A3B21763-2233-43B0-B3FF-2DAF6ABA9C9FQ43685509-C593773B-A525-4719-916F-9C51D1DA5B15Q44417645-5597E3C1-B8EB-4A8C-B7DD-4822995C9D26Q46829724-C8382D7F-D3DA-4AE6-A185-7D72799BB10FQ46832082-53BE46C3-C560-47CE-BDBC-F455B277F287Q48291812-E8A2B1A4-D875-4354-B44F-351D1BB88C25Q49076069-CB112CE9-2433-41FC-902D-5D60CA221EA1Q57024083-7A674ED1-EA3B-463F-A23B-3CA9EBD124F1Q57024171-258D4481-47B6-4487-8C6A-1593A13AAB29Q57024298-EB4A6AE2-AC62-47B5-A26F-FBE6DB1139ABQ57024321-AFD47CF5-5DD0-4FBB-BBF3-494FCE8E8F05Q57024341-B8FCAC8F-140F-4CC0-A2D6-A41615279FD8Q57024348-EB88EF23-FA93-486B-A19C-5FDF00F60A87Q84612166-BDA579E8-CEB0-47F5-9A89-2A4928071B54Q84979091-B2C6A649-7710-4BE6-A442-58A6E7C295B0Q89139548-D7764CE0-E039-4662-BD4E-8512B80E5E96Q90764059-499A7045-34E0-4274-B382-A85E88661A96Q91777011-0E7CFF52-7749-4730-8717-B051ADBC797EQ91786331-F3C60A8C-FEB7-4450-97AB-61C33113DE1CQ92499691-C1C8C814-EE5D-4388-AF3F-C4F2EC48FBBCQ93156909-E6692332-DCC5-4E28-9B6B-3C359CAEE783Q95457200-4E595999-BEDC-4EC7-970D-18F22D720936
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9417-2481
@en
name
Jakob Møller Hansen
@ast
Jakob Møller Hansen
@en
Jakob Møller Hansen
@es
Jakob Møller Hansen
@nl
type
label
Jakob Møller Hansen
@ast
Jakob Møller Hansen
@en
Jakob Møller Hansen
@es
Jakob Møller Hansen
@nl
prefLabel
Jakob Møller Hansen
@ast
Jakob Møller Hansen
@en
Jakob Møller Hansen
@es
Jakob Møller Hansen
@nl
P106
P1153
24780370100
P31
P496
0000-0002-9417-2481